Securing the Post-Covid Pharma Supply Chain: An Empirical Investigation

The pandemic outbreak of Covid-19 has shown the fragilities and vulnerabilities of the Pharma Supply Chain (PSC), leading academics and practitioners to rethink PSCs’ flexibility, agility, responsiveness, and resilience. This paper investigates how to secure the Post-Covid PSC by (i) classifying the challenges born of or aggravated by the pandemic; (ii) understanding how solutions enabled by Industry 4.0 technologies can be integrated into a framework to address and solve the above challenges. A theoretical framework was developed from a literature review to achieve these objectives, which was then confirmed and enriched by a multiple case study investigation.